News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Alnylam Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Making Sense of Alnylam’s Recent Stock Surge
May 26, 2016
·
3 min read
Job Trends
What’s at the Heart of Alnylam’s Company Culture?
May 20, 2016
·
5 min read
Genetown
10 Massachusetts Biotechs Devoting the Most Cash to R&D
May 5, 2016
·
3 min read
Job Trends
Alnylam Breaks Ground on New $200 Million Manufacturing Facility in Massachusetts, Adding 150 Jobs
April 28, 2016
·
4 min read
Drug Development
Alnylam’s John Maraganore Provides Leadership for RNAi Development and Biotech Industry
April 1, 2016
·
7 min read
Drug Development
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
March 23, 2016
·
3 min read
Deals
Three Potential Takeover Targets for Amgen
March 10, 2016
·
3 min read
Job Trends
Alnylam to Build $200 Million Site in Massachusetts that Will Employ 200+ Workers
February 12, 2016
·
2 min read
Job Trends
Alnylam’s Human Resources Boss Provides Hiring Strategy, Planning to Hire 1,500 By 2020
December 9, 2015
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Bay
Vir and Alnylam to Webcast Virtual Fireside Chat at H.C. Wainwright Hepatitis B Virus Mini-Conference
October 13, 2020
·
2 min read
Drug Development
Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six
September 30, 2020
·
13 min read
Genetown
Alnylam to Webcast Presentation at Chardan Virtual 4th Annual Genetic Medicines Conference
September 28, 2020
·
2 min read
Genetown
Alnylam Highlights Prospects for Building an Industry-Leading ATTR Amyloidosis Franchise at RNAi Roundtable
September 3, 2020
·
14 min read
Genetown
Alnylam to Webcast Presentations at Upcoming September 2020 Investor Conferences
September 2, 2020
·
2 min read
Business
Blackstone and Alnylam Close $150 Million R&D Financing to Advance RNAi Therapeutics for Cardiovascular Disease
August 17, 2020
·
8 min read
Business
Alnylam Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Period Activity
August 6, 2020
·
34 min read
Business
Alnylam Announces Planned Transition of Barry Greene, President
August 6, 2020
·
9 min read
Policy
Alnylam Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis (NASH)
August 3, 2020
·
8 min read
Business
Alnylam to Webcast Conference Call Discussing Second Quarter 2020 Financial Results
July 23, 2020
·
2 min read
